Ci-1Homo sapiens (Human)Cancer cell line

Also known as: Ci1, CI1, CI-1

🤖 AI SummaryBased on 6 publications

Quick Overview

Human B-cell lymphoma cell line with EBV infection.

Detailed Summary

Ci-1 is a human B-cell lymphoma cell line established from a patient with non-convoluted-cell lymphoblastic lymphoma. It is EBV-negative, as determined by the absence of EBV nuclear antigen (EBNA) expression. The cell line exhibits a 14q+ chromosomal abnormality, which is commonly associated with Burkitt's lymphoma. Ci-1 has been used in studies investigating EBV infections in cell lines and their potential impact on cellular transformation and oncogenesis. The cell line is part of the Cancer Cell Line Encyclopedia (CCLE) and has been characterized for its genetic and immunological properties.

Research Applications

EBV infection studiesChromosomal abnormality analysisCancer cell line characterization

Key Characteristics

EBV-negative14q+ chromosomal abnormalityB-cell lineage
Generated on 6/17/2025

Basic Information

Database IDCVCL_1861
SpeciesHomo sapiens (Human)
Tissue SourceAscites[UBERON:UBERON_0007795]

Donor Information

Age38
Age CategoryAdult
SexFemale

Disease Information

DiseaseB-cell non-Hodgkin lymphoma
LineageLymphoid
SubtypeMature B-Cell Neoplasms
OncoTree CodeMBN

DepMap Information

Source TypeDSMZ
Source IDACH-000687_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Thr211Ala (c.631A>G)Heterozygous-Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,12
D13S317
10,12
D16S539
8,12
D18S51
13,17
D19S433
15,16
D21S11
29,30
D2S1338
23,24
D3S1358
15,17
D5S818
11,12
D7S820
11,13
D8S1179
14,16
FGA
21
Penta D
11
Penta E
7,12
TH01
6,9.3
TPOX
8,11
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Screening human cell lines for viral infections applying RNA-Seq data analysis.

Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.

PLoS ONE 14:E0210404-E0210404(2019).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.

O'Grady T., Baddoo M., Fewell C., Renne R., Flemington E.K.

J. Virol. 89:713-729(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.

Uphoff C.C., Denkmann S.A., Steube K.G., Drexler H.G.

J. Biomed. Biotechnol. 2010:904767.1-904767.23(2010).

The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.

Quentmeier H., Drexler H.G.

Leukemia 10:142-149(1996).

Establishment and characterization of three new malignant lymphoid cell lines.

White H., Catovsky D., Foroni L., Luzzatto L., Goldman J.M.

Int. J. Cancer 39:89-93(1987).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).